Depth you cannot fake.
When your leadership needs fall within these four practice areas, or at the intersection of them, tell us what you are looking for and we will outline an approach tailored to your search.
Where We Work
Biotech, diagnostics, medical technology, and pharmaceutical companies from venture backed through commercial stage, including first executive builds for companies scaling past the founder-led stage.
Roles We Place
Chief Executive Officer, Chief Commercial Officer, Chief Medical Officer, Chief Scientific Officer, Chief Financial Officer, Chief Operating Officer, Regulatory Affairs and Quality leadership, Head of People, VP and above across commercial, clinical, regulatory, and operations.
Who We Serve
From Seed to the Fortune 100
Our life sciences practice has served venture backed startups building their first commercial team, private equity portfolio companies in transition, mid-cap and large-cap public companies, and Fortune 100 pharmaceutical and medical technology organizations, along with the investors behind them.
Venture backed companies
first executive builds and pre-commercial leadership.
Diagnostics and precision medicine
commercial and operating leadership ahead of scale.
Private equity portfolio companies
leadership for value creation and exit readiness.
Medical devices and medtech
with a specialization in ophthalmology dating to 2008.
Public companies
mid-cap through Fortune 100.
Pharmaceuticals
from emerging specialty pharma to global organizations.
Biotech and cell and gene therapy
two decades of relationships in the field.
CDMOs, CROs, and
life sciences services
the companies the industry runs on.
Functional Depth Across the Enterprise
Commercial and Market Access
Medical Affairs
Clinical Development
Regulatory Affairs
Quality
Manufacturing and Supply Chain
Research and Development
Finance
People and Culture
Business Development and Corporate Strategy
Why It Matters Here
1
2
3
Networks built over years
Investor fluency
Live visibility and evidence
We understand board dynamics, funding stages, and what a Series B company needs that a Fortune 100 company does not.
Relationships across biotech, pharma, medtech, and the investor community that were years in the making before your search began.
Every client sees their search in real time, with a validated assessment layer available on any engagement.